Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline.
MAbs. 2020 Jan-Dec;12(1):1854149. doi: 10.1080/19420862.2020.1854149.
MAbs. 2020.
PMID: 33319649
Free PMC article.